BPT567

· Bright Peak Therapeutics Inc

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BPT567, covering 2026-04-22 to 2026-04-22. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate Safety and Tolerability of BPT567 in Patients With Advanced Solid Tumors [Phase 1]